Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
16
NCT01010880
Safety Study of a Chemokine Receptor (CXCR4) Antagonist in Multiple Myeloma Patients
Phase: Phase 1/2
Role: Lead Sponsor
Start: Oct 31, 2008
Completion: Jul 31, 2010